Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Staphylococcus aureus and vancomycin: the sequel.

× No keyword cloud information.

15 in total

1. Analysis of vancomycin population susceptibility profiles, killing activity, and postantibiotic effect against vancomycin-intermediate Staphylococcus aureus.

Authors: J R Aeschlimann; E Hershberger; M J Rybak
Journal: Antimicrob Agents Chemother Date: 1999-08 Impact factor: 5.191

2. Pharmacokinetics, serum inhibitory and bactericidal activity, and safety of telavancin in healthy subjects.

Authors: J P Shaw; J Seroogy; K Kaniga; D L Higgins; M Kitt; S Barriere
Journal: Antimicrob Agents Chemother Date: 2005-01 Impact factor: 5.191

3. Short-course gentamicin in combination with daptomycin or vancomycin against Staphylococcus aureus in an in vitro pharmacodynamic model with simulated endocardial vegetations.

Authors: Brian T Tsuji; Michael J Rybak
Journal: Antimicrob Agents Chemother Date: 2005-07 Impact factor: 5.191

4. Vancomycin Serum Concentration Monitoring : The Middle Ground is Best.

Authors: F Marra; B Cairns; P Jewesson
Journal: Clin Drug Investig Date: 1996-08 Impact factor: 2.859

5. Prevalence and outcomes of antimicrobial treatment for Staphylococcus aureus bacteremia in outpatients with ESRD.

Authors: Kevin E Chan; H Shaw Warren; Ravi I Thadhani; David J R Steele; Jeffrey L Hymes; Franklin W Maddux; Raymond M Hakim
Journal: J Am Soc Nephrol Date: 2012-08-16 Impact factor: 10.121

6. Prospective evaluation of a two-week course of intravenous antibiotics in intravenous drug addicts with infective endocarditis. Grupo de Estudio de Enfermedades Infecciosas de la Provincia de Cádiz.

Authors: M Torres-Tortosa; M de Cueto; A Vergara; A Sánchez-Porto; E Pérez-Guzmán; M González-Serrano; J Canueto
Journal: Eur J Clin Microbiol Infect Dis Date: 1994-07 Impact factor: 3.267

7. The management of infection and colonization due to methicillin-resistant Staphylococcus aureus: A CIDS/CAMM position paper.

Authors: Andrew E Simor; Mark Loeb
Journal: Can J Infect Dis Date: 2004-01

8. Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia.

Authors: George Sakoulas; Pamela A Moise-Broder; Jerome Schentag; Alan Forrest; Robert C Moellering; George M Eliopoulos
Journal: J Clin Microbiol Date: 2004-06 Impact factor: 5.948

9. Teicoplanin alone or combined with rifampin compared with vancomycin for prophylaxis and treatment of experimental foreign body infection by methicillin-resistant Staphylococcus aureus.

Authors: H J Schaad; C Chuard; P Vaudaux; F A Waldvogel; D P Lew
Journal: Antimicrob Agents Chemother Date: 1994-08 Impact factor: 5.191

10. Trends in incidence and susceptibility among methicillin-resistant Staphylococcus aureus isolated from intranasal cultures associated with rhinosinusitis.

Authors: Valin Rujanavej; Ethan Soudry; Niaz Banaei; Ellen Jo Baron; Peter H Hwang; Jayakar V Nayak
Journal: Am J Rhinol Allergy Date: 2013 Mar-Apr Impact factor: 2.467